chymase inhibitors (J&J)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namechymase inhibitors (J&J)
Drug Alias Namebeta-ketophosphonates (J&J)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin G inhibitorsChymase inhibitors
TargetsChymaseCathepsin G
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A